The U.S. Food and Drug Administration on Tuesday gave the nod to Emgality, an injected medication that’s the first to cut the frequency of cluster headaches. 6-5-19.

Read more here.

Subscribe To Our Weekly Newsletter

Subscribe To Our Weekly Newsletter

Get a weekly digest of our posts straight to your inbox! We promise, no spam ever.

You have Successfully Subscribed!

Pin It on Pinterest

Share This